733
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Apocynin decreases AGEs-induced stimulation of NF-κB protein expression in vascular smooth muscle cells from GK rats

, , , &
Pages 488-493 | Received 20 Jan 2014, Accepted 11 May 2014, Published online: 04 Dec 2014

References

  • Brownlee M. (1995). The pathological implications of protein glycation. Clin Invest Med 18:275–81
  • Calnek DS, Mazzella L, Roser S, et al. (2003). Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol 23:52–7
  • Csiszar A, Smith K, Labinskyy N, et al. (2006). Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: Role of NF-κB inhibition. Am J Physiol Heart Circ Physiol 291:1694–9
  • de Oliveira Silva C, Delbosc S, Araïs C, et al. (2008). Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats. Nutr Metab Cardiovas Dis 1:23–30
  • Diep QN, Amiri F, Touyz RM, et al. (2002). PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 40:866–71
  • Faure P, Ramon O, Favier A. (2001). Glucose and redox sensitive transcription factors: Consequences on the insulin receptor. J Soc Biol 195:383–5
  • Ferreira FM, Palmeira CM, Matos MJ, et al. (1999). Decreased susceptibility to lipid peroxidation of Goto–Kakizaki rats: Relationship to mitochondrial antioxidant capacity. Life Sci 65:1013–125
  • Goto Y, Kakizaki M, Masaki N. (1976). Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 119:85–90
  • Guzik TJ, Harrison DG. (2006). Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov 11:524–33
  • Hwang J, Kleinhenz DJ, Lassègue B, et al. (2005). Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 288:C899–905
  • Hwang J, Kleinhenz DJ, Rupnow HL, et al. (2007). The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice. Vasc Pharmacol 46:456–62
  • Jones SA, O'Donnell VB, Wood JD, et al. (1996). Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 271:1626–34
  • Liu S, Ma X, Gong M, et al. (2007). Glucose down-regulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Free Radic Biol Med 42:852–63
  • Martín A, Pérez-Girón JV, Hernanz R, et al. (2012). Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress. J Hypertens 30:315–26
  • Meyer JW, Schmitt ME. (2000). A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett 472:1–4
  • Oliveira PJ, Rolo AP, Seiça R, et al. (2001). Decreased susceptibility of heart mitochondria from diabetic GK rats to mitochondrial permeability transition induced by calcium phosphate. Biosci Rep 21:45–53
  • Oliveira PJ, Rolo AP, Seiça R, et al. (2002). Impact of diabetes on induction of the mitochondrial permeability transition. Rev Port Cardiol 21:759–66
  • Parés-Herbuté N, Hillaire-Buys D, Etienne P, et al. (1996). Adenosine inhibitory effect on enhanced growth of aortic smooth muscle cells from streptozotocin-induced diabetic rats. Br J Pharmacol 118:783–9
  • Polikandriotis JA, Mazzella LJ, Rupnow HL, Hart CM. (2005). Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma dependent mechanisms. Arterioscler Thromb Vasc Biol 25:1810–16
  • Rosengren AH, Jokubka R, Tojjar D, et al. (2010). Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 327:217–20
  • Satriano J, Schlondorff D. (1994). Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate. Evidence for involvement of reactive oxygen species. J Clin Invest 94:1629–36
  • Schmidt AM, Stern DM. (2000). Hyperinsulinemia and vascular dysfunction: The role of nuclear factor kappa B yet again. Circ Res 87:722–4
  • Tawfik A, Sanders T, Kahook K, et al. (2009). Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: Role of NADPH oxidase. Invest Ophthalmol Vis Sci 50:878–84
  • Tian N, Moore RS, Phillips WE, et al. (2008). NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J physiol Regul Integr Comp Physiol 295:1858–65
  • Xu M, Dai DZ, Dai Y. (2009). Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in rats. Am J Nephrol 29:252–6
  • Yagihashi S, Goto Y, Kakizaki M, Kaseda N. (2002). Thickening of glomerular basement membrane in spontaneously diabetic rats. Diabetologia 15:309–12
  • Yasuda K, Nishikawa W, Iwanaka N, et al. (2002). Abnormality in fibre type distribution of soleus and plantaris muscles in non-obese diabetic Goto–Kakizaki rats. Clin Exp Pharmacol Physiol 29:1001–8
  • Yerneni KK, Bai W, Khan BV, et al. (1999). Hyperglycemia-induced activation of nuclear transcription factor kB in vascular smooth muscle cells. Diabetes 48:855–64
  • Zhang M, Kho AL, Anilkumar N, et al. (2006). Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: Involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation 113:1235–43

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.